Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study
Introduction Proton pump inhibitors (PPIs) are widely used for primary and secondary prevention of upper gastrointestinal bleeding. However, there remains controversy about the overall net clinical benefit of PPIs (omeprazole, rabeprazole, pantoprazole, lansoprazole) when coprescribed with direct or...
Saved in:
| Main Authors: | Lehana Thabane, Lawrence Mbuagbaw, Michael Paterson, Laura Targownik, Mei Wang, Anne Holbrook, Deborah Siegal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/6/e057991.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol
by: Lehana Thabane, et al.
Published: (2020-09-01) -
Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors
by: O. D. Ostroumova, et al.
Published: (2019-11-01) -
129 Risk Mitigation of Gastrointestinal Bleeding in Patients Co-Prescribed Antiplatelets with Oral Anticoagulants: VISN 8 Anticoagulation Stewardship Proton Pump Inhibitor Initiative
by: David Parra, et al.
Published: (2025-05-01) -
Current Physician's Perception of Proton Pump Inhibitor-related Adverse Effects
by: Cheol Woong Choi
Published: (2021-03-01) -
Proton-pump inhibitors
by: Vasudevan G. Naidoo
Published: (2015-05-01)